Concepedia

Author

M Šustrová

Slovak Medical University

Also Known As

M Sustrova, M Sustrová, M Šustrová, M. Sustrova, M. S̆ustrová, M. Šustrová, Maria Sustrova, Mária S̆ustrová, Mária Šustrová

24

Publications

434

Citations

11

H-Index

43

Concepts

All Affiliations

Slovak Medical UniversityComenius University BratislavaRhode Island Hospital
MŠ

About

M Šustrová is an author at Slovak Medical University specializing in medicine, down syndrome, and oxidative stress.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

294

2

Education

1

1

35

3

Health Sciences

1

1

31

4

Public Health

1

1

35

5

Allergy

1

1

12

M Šustrová

×

12

Publications

401

Citations

11

H-Index

YearCitations

Influence of age on activities of antioxidant enzymes and lipid peroxidation products in erythrocytes and neutrophils of down syndrome patients

Jana Muchová, M Šustrová, Iveta Garaiová,

Free Radical Biology and Medicine

2001

96

Uric acid and allantoin levels in Down syndrome: antioxidant and oxidative stress mechanisms?

Ingrid Žitňanová, Peter Korytár, Okezie I. Aruoma,

Clinica Chimica Acta

2004

93

Plasma concentrations of selected antioxidants in autistic children and adolescents.

M Krajcovicová-Kudlácková, Martina Valachovičová, Csilla Mišľanová,

PubMed

2009

35

Markers of oxidative stress in children with Down syndrome

Ingrid Žitňanová, Peter Korytár, Hana Sobotová,

Clinical Chemistry and Laboratory Medicine (CCLM)

2006

34

Serum lipid resistance to oxidation and uric acid levels in subjects with Down's syndrome.

A Nagyová, M Šustrová, Katarı́na Rašlová

PubMed

2000

31

Changed serum trace element profile in Down's syndrome

J Kadrabová, A Madarić, M Šustrová,

Biological Trace Element Research

1996

27

Thyroid function and plasma immunoglobulins in subjects with Down’s syndrome (DS) during ontogenesis and zinc therapy

M Šustrová, V Strbák

Journal of Endocrinological Investigation

1994

24

Serum Lipid Resistance to Oxidation and Uric Acid Levels in Subjects with Down's s Syndrome

A Nagyová, M Šustrová, Katarı́na Rašlová

Physiological Research

2000

15

Impact of interleukin 13 (<i>IL13</i>) genetic polymorphism Arg130Gln on total serum immunoglobulin (IgE) levels and interferon (IFN)-γ gene expression

Božena Smolková, Jana Tulinská, Ľubica Palkovičová,

Clinical & Experimental Immunology

2017

13

[Down's syndrome--effect of increased gene expression in chromosome 21 on the function of the immune and nervous system].

M Šustrová, V Saríková

PubMed

1997

12

Page 1